The Meneo Law Group



Overview
Diabetes Drug-Induced Pancreatic and Thyroid Cancers

Drugs to treat diabetes have been available for many years. Their development by medical science has ushered in a new class of diabetes drugs referred to as “GLP-1 Agents” – so named for the human hormone which is the target of their action.

byetta

The GLP-1 agents come in two forms – injectibles and oral agents. The injectibles are Byetta (exenalide) and Victoza (liraglutide). The oral agents are Januvia (sitagliptin), Onglyza (saxagliptin) and Tradjenta (linagliptin).

Recent epidemiological studies have demonstrated an association between two of these agents – Byetta and Januvia – and pancreatic cancer. The studies also signaled an association between Byetta and Victoza and thyroid cancer.

If you or a loved one developed pancreatic or thyroid cancer while being treated with Byetta, Januvia and/or Victoza, we would like to speak with you. Please send us your contact information and we will contact you within 24 hours

The GLP-1 Diabetes Medications – Mechanism of Action, Research Studies and FDA Statements

10 Reasons to Hire The Meneo Law Group
Meneo Law Group's team of dedicated professionals strives for excellence in all that we do. Our mission is to provide our clients with effective, professional and thorough legal representation and to do so in a diligent and ethical manner that helps our clients achieve and maximize their legal objectives.

DISCLAIMER


Serving Clients Nationwide
Practice Area Spotlight


E-CONTACT FORM
Name:
State:
Email:
Phone:
A value is required.
Please include a phone number.

Area Code plus 7 digits.

Ten digits maximum.
use numbers only-include area code
Best Time to Call:
Condition developed:


GLP-1 Agents

In the News: New York Times
Link: A Lone Voice Raises Alarms on Lucrative Diabetes Drugs

Investigation of Legal Implications

Our firm is currently investigating potential cases of GLP-1 drug-induced pancreatic and thyroid cancer on behalf of our clients. If you were (or a loved one was) taking Byetta, Januvia or Victoza and diagnosed with pancreatic or thyroid cancer, we would like the opportunity to talk with you.

No-Cost Review:
If you or a loved one developed pancreatic or thyroid cancer while being treated with Byetta, Januvia and/or Victoza, we would like to speak with you. Please send us your contact information and we will contact you within 24 hours

Patients should continue taking their medications as directed until they talk to their health care professionals


Drug

If you or a loved one developed pancreatic or thyroid cancer while being treated with Byetta, Januvia and/or Victoza, we would like to speak with you. Please send us your contact information and we will contact you within 24 hours


Contact Us for a free case evaluation
A value is required.Invalid format.



The Meneo Law Group
1-888-276-3030
Connecticut
Gold Building
234 Church Street, 10th Floor
New Haven, CT 06510


If you have questions regarding your legal rights, please contact us.

Copyright © 2009 The Meneo Law Group, All Rights Reserved.